http://www.bloomberg.com/apps/news?pid=20601202&sid=aUWFjYXhwymU&refer=healthcare
Lovenox has lost its patent, and is available to become generic. It may take a while, as it's described as a "complex biological drug derived from pig's intestines" which is hard to copy. Momenta Pharmaceuticals is probably the closest to creating a generic version right now.
Lovenox is low molecular weight heparin, which is commonly used in injections to bridge people on and off of Coumadin/warfarin ACT for surgeries and invasive procedures. Heparin is the choice for ACT during surgeries as its anticoagulant action can be turned on or off in the body in minutes with chemicals, depending on the patient's coagulation needs. Long-term, patients can develop a tolerance to it, and their bodies can even learn to defeat its action, so it's usually limited to short bridging procedures.
Plavix is also in the middle of patent litigation. Plavix is a different type of anticoagulant, and isn't effective for ACT for carbon valves.
Best wishes,
Lovenox has lost its patent, and is available to become generic. It may take a while, as it's described as a "complex biological drug derived from pig's intestines" which is hard to copy. Momenta Pharmaceuticals is probably the closest to creating a generic version right now.
Lovenox is low molecular weight heparin, which is commonly used in injections to bridge people on and off of Coumadin/warfarin ACT for surgeries and invasive procedures. Heparin is the choice for ACT during surgeries as its anticoagulant action can be turned on or off in the body in minutes with chemicals, depending on the patient's coagulation needs. Long-term, patients can develop a tolerance to it, and their bodies can even learn to defeat its action, so it's usually limited to short bridging procedures.
Plavix is also in the middle of patent litigation. Plavix is a different type of anticoagulant, and isn't effective for ACT for carbon valves.
Best wishes,
